In the BioHarmony Drug Report Database

"Preview" Icon

Lesinurad

Zurampic (lesinurad) is a small molecule pharmaceutical. Lesinurad was first approved as Zurampic on 2015-12-22. It is used to treat hyperuricemia in the USA. It is known to target solute carrier family 22 member 12. Zurampic’s patents are valid until 2032-02-29 (FDA).

 

Trade Name

 

Zurampic
 

Common Name

 

lesinurad
 

ChEMBL ID

 

CHEMBL2105720
 

Indication

 

hyperuricemia
 

Drug Class

 

Urate transporter inhibitors

Image (chem structure or protein)

Lesinurad structure rendering